Dr. Jonathan E. Hullmann, MD

Dr. Hullmann practices at Penn Medicine Doylestown Health in Doylestown, Pennsylvania.

Dr. Hullmann's NPI, 1275996514, was assigned on April 4, 2016. Dr. Hullmann holds Pennsylvania license MD465656.

Dr. Hullmann's primary practice is Penn Medicine Doylestown Health, at 595 W State St, Doylestown, PA 18901 in Bucks County. The practice phone is (215) 345-2321.

Dr. Hullmann's primary practice is Penn Medicine Doylestown Health in Doylestown, Pennsylvania. Dr. Hullmann is also affiliated with Doylestown Hospital. The medical group on file is Clinical Specialty Associates. Dmand AI also links Dr. Hullmann to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hullmann practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hullmann's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Hullmann is licensed in Pennsylvania.

CMS data shows 3,211 Medicare services from Dr. Hullmann across 27 procedure codes in 2024, for 1,411 Medicare patients. Medicare paid $136,502 for them.

CMS counts 1,411 Medicare patients who saw Dr. Hullmann in 2024. The largest group is 75 to 84, with 600 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hullmann's median patient age at 76, with 48% women.

In 2024, Dr. Hullmann wrote 2,019 Medicare Part D claims for 346 patients. 85% of them were for generic drugs. CMS names the drug for 1,870 of them, across 29 drugs with 11 or more claims each, at $354,219 in total drug cost. In 2023, CMS named 1,051 claims across 21 drugs.

Dr. Hullmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Hullmann, published from 2013 to 2018. 2016 was the busiest year, with 2. The most frequent topics are G-Protein-Coupled Receptor Kinase 5, Heart Failure and Mice, Transgenic. Dr. Hullmann has published most often in Circ Res. Dr. Hullmann's most frequent co-authors are Jessica Gold, DO and Paul J. Mather, MD.

CMS Open Payments shows 155 general payments to Dr. Hullmann from 25 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $475.